Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$356.01 - $451.55 $2,848 - $3,612
8 Added 10.67%
83 $35.7 Million
Q1 2024

Apr 26, 2024

BUY
$356.95 - $413.29 $356 - $413
1 Added 1.35%
75 $29.5 Million
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $25,079 - $37,444
74 New
74 $28.2 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Systm Wealth Solutions LLC Portfolio

Follow Systm Wealth Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systm Wealth Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Systm Wealth Solutions LLC with notifications on news.